Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 63, Issue 10, 2004, Pages 1222-1226

  Fransen, J ^a   Laan, R F J M ^a   Van Der Laar, M A F J ^b   Huizinga, T W J ^c   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOXICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DECISION MAKING; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; GUIDELINE ADHERENCE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PRACTICE GUIDELINES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1542362385     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.018861     Document Type: Article

References (25)

1. Wolfe F, Cush JJ, O'Dell JR, Kavanaugh A, Kremer JM, Lane NE, et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001;28:1423-30.
2. Van Gestel AM, Van Riel PLCM. Evaluation of early rheumatoid arthritis disease activity and outcome. Baillieres Clin Rheumatol 1997;11:49-63.
3. Scott DL. Clinical guidelines for management. Baillieres Clin Rheumatol 1997;11:157-79.
4. Cibere J, Sibley JT, Haga M. Rheumatologists' adherence ta guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. J Rheumatol 2002;29:339-46.
5. Van Ede EA, Loan RFJM, Rood MJ, Huizinga TWJ, Van de Laar MAFJ, Van Denderen CJ, et al. Effect of folic or folinic supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis. A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001;44:1515-24.
6. Van der Heijde DMFM, Van't Hof MA, Van Riel PLCM, Van de Putte LBA. Development of a disease activity score bosed on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
7. Van Gestel AM, Prevoo MLL, Van't Hof MA, Van Rijswijk MH, Van de Putte LBA, Van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organisation/International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34-40.
8. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Q J Med 1968;37:393-406.
9. Fries JF, Spitz PW, Williams CA, Bloch DA, Sing G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-30.
10. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicily tradeoffs to select second-line drugs in rheumatoid arthritis. A meta-analysis of published clinical trials. Arthritis Rheum 1992;35:1117-25.
11. Verbeke G, Molenberghs G. Linear mixed models in practice. A SAS-oriented approach. New York: Springer Verlag, 1997.
12. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-respander bias. Stat Med 1984;3:35-44.
13. Cabana MD, Rushton JL, Rush AJ. Implementing practice guidelines for depression: Applying a new framework to an old problem. Gen Hosp Psychiatry 2002;24:35-42.
14. Fitzmaurice DA, Hobbs FD, Delaney BC, Wilson S, McManus R. Review of computerized decision support systems for oral anticoagulation management. Br J Haematol 1998;102:907-9.
15. Fitzmaurice DA, Hobbs FD, Murray ET, Bradley CP, Holder R. Evaluation of computerized decision support for oral anticoagulation management based in primary care. Br J Gen Pract 1996;46:533-5.
16. Johnston ME, Langton KB, Haynes B, Mathieu A. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann Intern Med 1994;120:135-42.
17. Hunt DL, Haynes B, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes. JAMA 1998;280:1339-46.
18. Vadher B, Patterson DL, Leaning M. Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial. BMJ 1997;314:1252-6.
19. Hetlevik I, Holmen J, Kruger O. Implementing clinical guidelines in the treatment of hypertension in general practice. Scand J Prim Health Care 1999;17:35-40.
20. Montgomery AA, Fahey T. A systematic review of the use of computers in the management of hypertension. J Epidemiol Community Health 1998;52:520-5.
21. Montgomery AA, Fahey T, Peters TJ, Macintosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 2000;320:686-90.
22. Herievik I, Holmen J, Kruger O, Kristensen P, Iversen H, Furuseth K. Implementing clinical guidelines in the treatment of diabetes mellitus in general practice, Int J Technol Assess Health Care 2000;16:210-27.
23. Den Broeder AA, Creemers MCW, Van Gestel AM, Van Riel PLCM. Dose titration using the disease activity score (DAS28) in rheumatoid arthritis patients treated with anti-TNFα. Rheumatology (Oxford) 2002;41:638-42.
24. Uitz E, Fransen J, Langenegger T, Stucki G. Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis. Rheumatology (Oxford) 2000;39:542-9.
25. Van Riel PLCM, Schumacher HR. How does one assess early rheumatoid arthritis in daily clinical practice? Best Pract Res Clin Rheumatol 2001;15:67-76.